09-PLEX: A phase II study evaluating the safety and efficacy of subcutaneous plerixafor for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells in recipients with hematological malignancies
|Effective start/end date||12/2/13 → 10/31/17|
- NATIONAL MARROW DONOR PROGRAM
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.